Expertise in
27
conditions

Dr. Janice Kerr

Endocrinology
University Of Colorado Hospital
1665 Aurora Ct Fl 2, 
Aurora, CO 
Expertise in
27
conditions
University Of Colorado Hospital
1665 Aurora Ct Fl 2, 
Aurora, CO 

Overview

Janice Kerr is an Endocrinologist in Aurora, Colorado. Dr. Kerr is highly rated in 27 conditions, according to our data. Her top areas of expertise are Pituitary Tumor, Prolactinoma, Acromegaly, and Thyroid Cancer.

Her clinical research consists of co-authoring 17 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Endocrinology

Licenses

Internal Medicine in CO

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Medica
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

University of Colorado Hospital
1665 Aurora Ct Fl 2, Aurora, CO 80045

Additional Areas of Focus

Dr. Kerr has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
Enrollment Status: Completed
Publish Date: December 18, 2024
Intervention Type: Drug
Study Drug: Osilodrostat
Study Phase: Phase 2
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: November 01, 2021
Intervention Type: Drug
Study Phase: Phase 3
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: January 06, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

17 Total Publications

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Role of Medical Perioperative Management for Patients With Functioning Pituitary Adenomas.
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Role of Medical Perioperative Management for Patients With Functioning Pituitary Adenomas.
Journal: Neurosurgery
Published: April 15, 2025
Similar Doctors
Expertise in
32
conditions
Dr. Margaret Wierman
Endocrinology
Expertise in
32
conditions
Dr. Margaret Wierman
Endocrinology

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
 (0.2 miles away)
720-848-2650
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Margaret Wierman is an Endocrinologist in Aurora, Colorado. Dr. Wierman is highly rated in 32 conditions, according to our data. Her top areas of expertise are Adrenocortical Carcinoma, Pituitary Tumor, Adrenal Cancer, Hypothalamic Tumor, and Hormone Replacement Therapy (HRT).

Bryan Haugen
Expertise in
9
conditions
Dr. Bryan Haugen
Endocrinology
Expertise in
9
conditions
Dr. Bryan Haugen
Endocrinology

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
 (0.2 miles away)
720-848-2650
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Bryan Haugen is an Endocrinologist in Aurora, Colorado. Dr. Haugen is highly rated in 9 conditions, according to our data. His top areas of expertise are Thyroid Cancer, Anaplastic Thyroid Cancer, Follicular Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Expertise in
13
conditions
Dr. Lauren Fishbein
Endocrinology
Expertise in
13
conditions
Dr. Lauren Fishbein
Endocrinology

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
 (0.2 miles away)
720-848-2650
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Lauren Fishbein is an Endocrinologist in Aurora, Colorado. Dr. Fishbein is highly rated in 13 conditions, according to our data. Her top areas of expertise are Pheochromocytoma, Multiple Endocrine Neoplasia Type 2, Neuroendocrine Tumor, and Adrenal Cancer.

Frequently Asked Questions about Dr. Janice Kerr

How do I make an appointment with Dr. Janice Kerr?

You can book an appointment with Dr. Janice Kerr by calling their office at 720-848-0000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Janice Kerr a top-rated expert for Pituitary Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Janice Kerr is classified as an Distinguished expert for Pituitary Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Janice Kerr specialize in?

While Dr. Janice Kerr is a Endocrinology, they have specific expertise in Pituitary Tumor, Prolactinoma, and Acromegaly. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. Janice Kerr participate in research or clinical trials?

Yes. Dr. Janice Kerr has published 17 articles and abstracts on conditions like Pituitary Tumor. You can view a list of Dr. Janice Kerr's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Janice Kerr accept my insurance?

Dr. Janice Kerr accepts most major insurance plans, including Medica and UnitedHealthcare. We recommend calling the office directly at 720-848-0000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kerr's expertise for a condition
ConditionClose
    View All 21 Advanced Conditions
    View All 42 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile